<!DOCTYPE html>
<html lang="en">

  <head>
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <title>About</title>
  <meta name="description" content="by Dr Mark Wardle, Consultant Neurologist, clinical informatics and software developer. Founder, Eldrix Ltd.">

  <link rel="stylesheet" href="/assets/main.css">
  <link rel="canonical" href="https://www.wardle.org/about/">
  <link rel="alternate" type="application/rss+xml" title="Health informatics and information technology" href="/feed.xml">
  
  <script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-97389603-1', 'auto');
  ga('send', 'pageview');

</script>
</head>


  <body>

    <header class="site-header" role="banner">

  <div class="wrapper">
    
    
    <a class="site-title" href="/">Health informatics and information technology</a>
  
  
    
      <nav class="site-nav">
        <input type="checkbox" id="nav-trigger" class="nav-trigger" />
        <label for="nav-trigger">
          <span class="menu-icon">
            <svg viewBox="0 0 18 15" width="18px" height="15px">
              <path fill="#424242" d="M18,1.484c0,0.82-0.665,1.484-1.484,1.484H1.484C0.665,2.969,0,2.304,0,1.484l0,0C0,0.665,0.665,0,1.484,0 h15.031C17.335,0,18,0.665,18,1.484L18,1.484z"/>
              <path fill="#424242" d="M18,7.516C18,8.335,17.335,9,16.516,9H1.484C0.665,9,0,8.335,0,7.516l0,0c0-0.82,0.665-1.484,1.484-1.484 h15.031C17.335,6.031,18,6.696,18,7.516L18,7.516z"/>
              <path fill="#424242" d="M18,13.516C18,14.335,17.335,15,16.516,15H1.484C0.665,15,0,14.335,0,13.516l0,0 c0-0.82,0.665-1.484,1.484-1.484h15.031C17.335,12.031,18,12.696,18,13.516L18,13.516z"/>
            </svg>
          </span>
        </label>

        <div class="trigger">
           <a class="page-link" href="/">All posts</a>
          
            
            
            <a class="page-link" href="/about/">About</a>
            
          
            
            
          
            
            
          
            
            
          
        </div>
      </nav>
    
  </div>
</header>


    <main class="page-content" aria-label="Content">
      <div class="wrapper">
        <article class="post">

  <header class="post-header">
    <h1 class="post-title">About</h1>
  </header>

  <div class="post-content">
    <p>Dr. Mark Wardle MB BCh MD FRCP</p>

<h1 id="employment">Employment</h1>

<ul>
  <li>Consultant Neurologist - <a href="http://www.cardiffandvaleuhb.wales.nhs.uk">Cardiff and Vale University Health Board</a>, 2011-</li>
  <li>Clinical databases lead and Principal Investigator, <a href="http://brain.wales">BRAIN unit</a>, 2013-</li>
  <li>Honorary Clinical Lecturer - <a href="http://www.cf.ac.uk">Cardiff University</a>, 2011-</li>
  <li>Clinical designer, <a href="http://www.wales.nhs.uk/nwis/">NHS Wales informatics services</a>, 2016-</li>
  <li>Clinical informatician, <a href="http://www.cardiffandvaleuhb.wales.nhs.uk">Cardiff and Vale University Health Board</a>, 2016-</li>
  <li>Founder, <a href="http://eldrix.com">Eldrix Ltd</a>, Electronic patient record software 2012-</li>
</ul>

<h1 id="past-employment">Past employment</h1>

<ul>
  <li>Deputy Sub-Dean for Assessments, School of Medicine, <a href="http://www.cf.ac.uk">Cardiff University</a>, 2012-2016</li>
</ul>

<h1 id="qualifications-and-prizes">Qualifications and prizes</h1>

<ul>
  <li>Fellowship of the Royal College of Physicians, 2015</li>
  <li>Doctorate of Medicine, Cardiff University, 2009 - <a href="/images/wardle-2009-thesis.pdf">Cerebellar ataxia: A clinical and genetic study in South Wales</a></li>
  <li>Sir Charles Symonds Prize, Association of British Neurologists, Best Platform Presentation, 2007</li>
  <li>Membership of the Royal College of Physicians, 2004</li>
  <li>MB BCh, University of Wales College of Medicine, 1999</li>
  <li>Elizabeth Pipe Prize in Paediatrics, 1999</li>
</ul>

<h1 id="grants">Grants</h1>

<ul>
  <li>Gray L et al. NIHSCR Wales BRAIN unit, £1,499,910 July 2015-</li>
  <li>Bisson J et al. Biobanking Research support, NIHSCR AHSC, £130,322, Apr 2012-Mar 2015</li>
</ul>

<h1 id="roles-and-responsibilities">Roles and responsibilities</h1>
<h4 id="clinical">Clinical</h4>

<ul>
  <li>General neurology, University Hospital Wales and Prince Charles Hospital	2011-
    <ul>
      <li>Two clinics per week</li>
      <li>Two ward referral sessions per week</li>
      <li>On-call for neurology and stroke thrombolysis</li>
    </ul>
  </li>
  <li>Specialist ataxia and movement disorders clinic, Cardiff and Vale		2011-
    <ul>
      <li>One clinic per week</li>
    </ul>
  </li>
  <li>Specialist motor neurone disease clinic: Prince Charles Hospital		2012-
    <ul>
      <li>One clinic per month</li>
    </ul>
  </li>
  <li>Clinical lead for IT for Welsh Clinical Portal project, Cardiff and Vale 		2011-2015</li>
  <li>Educational and clinical supervisor, Wales Deanery				2011-</li>
  <li>Medical expert for Court of Protection, December 2015</li>
</ul>

<h4 id="non-clinical">Non-clinical</h4>

<ul>
  <li>Member, “Once for Wales” Task and Finish Group, Welsh Assembly Government, 2017-</li>
  <li>Member, Welsh Clinical Informatics Council, NHS Wales Informatics Service, 2015-</li>
  <li>Information standards, Task and finish group, 2016-2017.</li>
  <li>Co-director, South Wales Motor Neurone Disease Network, 2015-</li>
  <li><a href="https://www.mndassociation.org/research/mnd-register-for-england-wales-and-northern-ireland/">National UK MND register</a> steering group, 2015-</li>
  <li>Clinical databases lead, NISCHR BRAIN unit, 2015-</li>
  <li>Association of British Neurologists Neurogenetics Advisory Group, 2015-</li>
  <li>Wales Neuromuscular network steering group, 2013-</li>
  <li>Medical Schools Council Assessment Alliance (MSA-AA) reference group	2012-2016</li>
  <li>Ataxia UK, medical advisory panel, 2012-</li>
  <li>Clinical advisor, Welsh Neurosciences Tissue Bank, 2012-</li>
</ul>

<h1 id="publications-and-abstracts">Publications and abstracts</h1>

<h4 id="publications">Publications</h4>

<ul>
  <li>
    <p>van de Zande NA, Massey TH, McLauchlan D, Pryce-Roberts A, Zutt R, Wardle M, Payne G, Clenaghan C, Tijssen MAJ, Rosser AE, Peall KJ. Clinical Characterisation of Dystonia in Patients with Huntington’s Disease. Eur J Neurol, 2017 [in press]</p>
  </li>
  <li>
    <p>Harding K, Tilling K, MacIver C, Willis M, Joseph F, Ingram G, Hirst C, Wardle M, Pickersgill TP, Robertson NP. Seasonal variation in multiple sclerosis relapse. J Neurol, 2017. doi:10.1007/s00415-017-8485-0</p>
  </li>
  <li>
    <p>Wardle M and Spencer A. <a href="http://m.futurehospital.rcpjournal.org/content/4/2/126">Implementation of SNOMED CT in an online clinical database</a>. Future Hosp J June 1, 2017 vol. 4 no. 2 126-130.</p>
  </li>
  <li>
    <p>Williams OH, Harding K, Rimmer A et al. Disease Modifying Treatments in MS: Clinical Outcomes of Induction and Escalation Strategies. MULTIPLE SCLEROSIS JOURNAL 2017:23 (2), 316-316.</p>
  </li>
  <li>
    <p>Harding KH, Williams OH, Willis MD et al. Socioeconomic Status and Disability in Multiple Sclerosis. MULTIPLE SCLEROSIS JOURNAL 23 (2), 322-322.</p>
  </li>
  <li>
    <p>Willis MD, Harding KE, Pickersgill TP, Wardle M, Pearson OR, Scolding NJ, Smee J, Robertson NP. <a href="https://www.ncbi.nlm.nih.gov/pubmed/26514979">Alemtuzumab for multiple sclerosis: Long term follow-up in a multi-centre cohort</a>. Mult Scler. 2016 Aug;22(9):1215-23. doi: 10.1177/1352458515614092.</p>
  </li>
  <li>
    <p>Wardle M, Sadler M <a href="http://pn.bmj.com/content/16/1/70">How to set up a clinical database</a> Practical Neurology 2016;16:70-74.</p>
  </li>
  <li>
    <p>Tallantyre EC, Wardle M, Robertson NP <a href="http://pn.bmj.com/content/16/1/62">How to run a multiple sclerosis relapse clinic</a> Practical Neurology 2016;16:62-69.</p>
  </li>
  <li>
    <p>Willis MD, Harding KE, Wardle M et al <a href="https://www.ncbi.nlm.nih.gov/pubmed/25196326">Site-specific clinical disease onset in multiple sclerosis.</a> Eur J Neurol. 2015 Apr;22(4):732-5. doi: 10.1111/ene.12564. Epub 2014 Sep 8.</p>
  </li>
  <li>
    <p>Peall KJ, Kurian MA, Wardle M et al. <a href="https://www.ncbi.nlm.nih.gov/pubmed/25209853">SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype.</a>
J Neurol. 2014 Dec;261(12):2296-304. doi: 10.1007/s00415-014-7488-3. Epub 2014 Sep 11.</p>
  </li>
  <li>
    <p>Harding KE, Wardle M, Moore P, Tomassini V, Pickersgill T, Ben-Shlomo Y, Robertson NP (2014). <a href="https://www.ncbi.nlm.nih.gov/pubmed/24828900">Modelling the natural history of primary progressive multiple sclerosis.</a> J Neurol Neurosurg Psychiatry. 2014 May 14. pii: jnnp-2014-307791.</p>
  </li>
  <li>
    <p>Peall KJ, Smith DJ, Kurian MA, Wardle M et al <a href="https://www.ncbi.nlm.nih.gov/pubmed/23365103">SGCE mutations cause psychiatric disorders: clinical and genetic characterization.</a> Brain. 2013 Jan;136(Pt 1):294-303.</p>
  </li>
  <li>
    <p>Moore P, Harding KE, Clarkson H, Pickersgill TP, Wardle M, Robertson NP (2013). <a href="http://journals.sagepub.com/doi/10.1177/1352458513481396">Demographic and clinical factors associated with changes in employment in multiple sclerosis.</a> Mult Scler. 2013 Oct;19(12):1647-54.</p>
  </li>
  <li>
    <p>Fawcett K, Mehrabian M, Liu YT, Hamed S, Elahi E, Revesz T, Koutsis G, Herscheson J, Schottlaender L, Wardle M, Morrison PJ, Morris HR, Giunti P, Wood N, Houlden H (2013) “The frequency of spinocerebellar ataxia type 23 in a UK population.” J Neurol. 2013 Mar;260(3):856-9. doi: 10.1007/s00415-012-6721-1. Epub 2012 Oct 30. Erratum in: J Neurol. 2013 Mar;260(3):860.</p>
  </li>
  <li>
    <p>Harding KE, Liang K, Cossburn MD, Ingram G, Hirst CL, Pickersgill TP, Te Water Naude J, Wardle M, Ben-Shlomo Y, Robertson NP (2013) “Long-term outcome of paediatric-onset multiple sclerosis: a population-based study.” J Neurol Neurosurg Psychiatry. 2013 Feb;84(2):141-7. doi: 10.1136/jnnp-2012-303996. Epub 2012 Nov 15.</p>
  </li>
  <li>
    <p>Becker EB, Zuliani L, Pettingill R, Lang B, Waters P, Dulneva A, Sobott F, Wardle M, Graus F, Bataller L, Robertson NP, Vincent A (2012) “Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia.” J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):437-40. doi: 10.1136/jnnp-2011-301506. Epub 2012 Feb 15.</p>
  </li>
  <li>
    <p>Wardle, M.; Morris H.; Robertson, N. (2009), ‘Clinical and genetic characteristics of non-Asian dentatorubral pallidoluysian atrophy: A systematic review’. Mov Disord 24(11):1636-40.</p>
  </li>
  <li>
    <p>Wardle, M. (2009), ‘Cerebellar ataxia: A clinical and genetic study in South Wales’, MD thesis, Cardiff University.</p>
  </li>
  <li>
    <p>Wardle, M.; Majounie, E.; Muzaimi, M.; Williams, N.; Morris, H. &amp; Robertson, N. (2009), ‘The genetic aetiology of chronic progressive cerebellar ataxia: a population-based study’, J Neurol 256 (3):343-8. Epub 2009 Mar 6.</p>
  </li>
  <li>
    <p>Wardle, M.; Majounie, E.; Williams, N.; Rosser, A.; Morris, H. &amp; Robertson, N. (2008), ‘Dentatorubral pallidoluysian atrophy in South Wales’, J Neurol Neurosurg Psychiatry 79, 804-807.</p>
  </li>
  <li>
    <p>Majounie, E.; Wardle, M.; Muzaimi, M.; Cross, W.; Robertson, N. P.; Williams, N. &amp; Morris, H. (2007), ‘Case control analysis of repeat expansion size in ataxia.’, Neurosci Lett 429, 28-32.</p>
  </li>
  <li>
    <p>Wardle, M. &amp; Robertson, N. (2007), ‘Progressive late-onset cerebellar ataxia’, ACNR 7, 6-12.  </p>
  </li>
</ul>

<h4 id="published-abstracts">Published abstracts</h4>

<ul>
  <li>
    <p><a name="iPadParkinson">B. Mohamed, E.L. Lane, E.C. Thomas, M. Landwehr, C.W. Ngu, J. Butler, K. Williams, M. Wardle. <a href="http://www.mdsabstracts.org/abstract/ipad-based-preassessment-questionnaires-are-feasible-in-a-parkinsons-service/">iPad-based preassessment questionnaires are feasible in a Parkinson’s service [abstract]</a>. Mov Disord. 2016; 31 (suppl 2).</a></p>
  </li>
  <li>
    <p>Harding K, Williams O, Willis M, Wardle M, Pickersgill T, Robertson NP. <a href="http://jnnp.bmj.com/content/87/12/e1.229">CONTEMPORARY ANALYSIS OF MORTALITY IN MULTIPLE SCLEROSIS</a> J Neurol Neurosurg Psychiatry 2016;87:e1.</p>
  </li>
  <li>
    <p>Healy S, Nasser T, Willis M, et al <a href="http://jnnp.bmj.com/content/87/12/e1.72">THYROID AUTOIMMUNITY FOLLOWING ALEMTUZUMAB TREATMENT FOR MS</a> J Neurol Neurosurg Psychiatry 2016;87:e1.</p>
  </li>
  <li>
    <p>DISEASE MODIFYING TREATMENTS IN MS: INDUCTION OR ESCALATION? Owain H Williams, Katharine E Harding, Mark Willis, Trevor Pickersgill, Mark Wardle, Neil P Robertson J Neurol Neurosurg Psychiatry 2015;86:11 e4 doi:10.1136/jnnp-2015-312379.29</p>
  </li>
  <li>
    <p>DISEASE MODIFYING TREATMENT UTILISATION IN MULTIPLE SCLEROSIS Owain H Williams, Katharine E Harding, Mark Willis, Trevor Pickersgill, Mark Wardle, Neil P Robertson. J Neurol Neurosurg Psychiatry 2015;86:11 e4 doi:10.1136/jnnp-2015-312379.125</p>
  </li>
  <li>
    <p>Clinical characteristics and genetic testing of a Huntingtin mutation negative cohort [abstract]. Peall, K.J., Morris, H.R., Wardle, M.; Movement Disorders 2015;30 Suppl 1 :362</p>
  </li>
  <li>
    <p>FACTORS ASSOCIATED WITH EMERGENCY ATTENDANCES FOR EPILEPSY Lynch EC, Lacey AS, Pickrell WO, Smith PEM, Wardle M. J Neurol Neurosurg Psychiatry 2014;85:10. doi:10.1136/jnnp-2014-309236.73</p>
  </li>
  <li>
    <p>NO TEMPORAL EFFECT ON DISABILITY IN MULTIPLE SCLEROSIS Katharine Harding, Mark Willis, Mark Wardle, Trevor Pickersgill, Neil Robertson J Neurol Neurosurg Psychiatry 2014;85:10 e4 doi:10.1136/jnnp-2014-309236.10</p>
  </li>
  <li>
    <p><a href="http://jnnp.bmj.com/content/85/10/e4.194.short">ALEMTUZUMAB: LONG TERM FOLLOW-UP IN A SINGLE CENTRE COHORT</a> Mark Willis, Katharine Harding, Mark Wardle et al. J Neurol Neurosurg Psychiatry 2014;85:10 e4 doi:10.1136/jnnp-2014-309236.8</p>
  </li>
  <li>
    <p>LATE–ONSET MULTIPLE SCLEROSIS IN SOUTH–EAST WALES Katharine Harding, Megan Griffiths, Mark Wardle, Valentina Tomassini, Trevor Pickersgill, Neil Robertson J Neurol Neurosurg Psychiatry 2013;84:11 e2 doi:10.1136/jnnp-2013-306573.26</p>
  </li>
  <li>
    <p>EPISTATIC EFFECTS ON THE PHENOTYPE OF MULTIPLE SCLEROSIS Harding K, Loveless S, Wardle M et al J Neurol Neurosurg Psychiatry 2013;84:11 e2</p>
  </li>
  <li>
    <p>Neighbourhood socioeconomic status and multiple sclerosis: the impact of area level deprivation on multiple sclerosis risk frequency and disease progression Moore P, Harding K, Wardle M, Pickersgill TP, Robertson NP. Mult Scler, October 2013; vol. 19, 11 suppl: pp. 74-558.</p>
  </li>
  <li>
    <p>ARE PSYCHIATRIC SYMPTOMS A CORE PHENOTYPE OF MYOCLONUS DYSTONIA SYNDROME CAUSED BY SGCE MUTATIONS? KJ Peall, DJ Smith, MA Kurian, M Wardle et al J Neurol Neurosurg Psychiatry 2013;84:9 e1 doi:10.1136/jnnp-2013-306103.24</p>
  </li>
  <li>
    <p>IL-7, IL-9 and IL-12 are associated with current aspects of disease, but do not predict disease course in multiple sclerosis Harding, KE; Cossburn, MD; Moore, P; Pickersgill, TP; Wardle, M; Robertson, NP. MULTIPLE SCLEROSIS JOURNAL 18;117-117 Supplement: 4.OCT 2012</p>
  </li>
  <li>
    <p>DO AGE AT ONSET OR GENDER AFFECT ACCUMULATION OF DISABILITY IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS? K Harding, L Curzon, P Moore, MD Cossburn, G Ingram, TP Pickersgill, M Wardle, NP Robertson J Neurol Neurosurg Psychiatry 2012;83:Suppl 2 A35</p>
  </li>
  <li>
    <p>REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME AS A CAUSE OF SUBARACHNOID HAEMORRHAGE K Ali, Y Joshi, S Halpin, M Wardle J Neurol Neurosurg Psychiatry 2012;83:Suppl 2 A1 doi:10.1136/jnnp-2012-304200a.1</p>
  </li>
  <li>
    <p>‘Late onset cerebellar ataxia: natural history and prognosis’, Wardle, M.; Muzaimi, M.; Robertson, N. J Neurol Neurosurg Psychiatry 2008 80,97-128</p>
  </li>
  <li>
    <p>‘DRPLA in South Wales’, Wardle, M.; Majounie, E.; Williams, N.; Rosser, A.; Morris, H. &amp; Robertson, N. J Neurol Neurosurg Psychiatry 2007;78, 1014-1038.</p>
  </li>
</ul>

<h1 id="software-and-clinical-informatics">Software and clinical informatics</h1>

<ul>
  <li><em>PatientCare</em> electronic patient record (EPR) application, 61,045 lines of Java code supporting the care of over 20,000 patients in Wales recording over 3,000 clinical encounters every month. A web-based portal used across Wales since 2009 recording information about a range of patients with different diseases linked to clinical services and research together with diagnostic and outcome information. It uses SNOMED CT as its lingua franca. It supports many services, including:
    <ul>
      <li>Multiple sclerosis; it is the largest multiple sclerosis registry in the United Kingdom</li>
      <li>Motor neurone disease; all patients in South Wales with motor neurone disease are registered together with longitudinal outcomes</li>
      <li>neuromuscular disease; all patients in Wales under the neuromuscular network</li>
      <li>Parkinson’s disease; all patients in Cardiff and Bridgend with Parkinson’s disease and related disorders</li>
      <li>Ataxia and movement disorders registry</li>
      <li>All-Wales epilepsy registry as well as supporting epilepsy surgery programme</li>
      <li>Metabolic medicine</li>
      <li>Botulinum toxin clinics</li>
      <li>Welsh Neurosciences Research Tissue Bank (WNRTB)</li>
    </ul>
  </li>
  <li><a href="https://msdata.org.uk">HealthContact portal</a>, an online portal for clinicians and patients using pseudonymisation to permit web-based and iOS-based remote access and data entry into the NHS-hosted PatientCare system.</li>
  <li><em>HealthContact</em> suite of iOS applications for use by patients in clinic and at home to record patient-reported outcomes integrating and communicating with the PatientCare EPR. The first Apple ResearchKit applications deployed in the United Kingdom (2015) and trialled in the Parkinson’s clinic.</li>
  <li><a href="https://github.com/wardle/rsterminology">rsterminology, a free open-source SNOMED-CT terminology server</a> built as a microservice, currently live within NHS Wales providing comprehensive search and browse functionality as well as understanding of semantic meaning and subsumption.</li>
</ul>

  </div>

</article>
        
      </div>
    </main>
    
    
    
    <footer class="site-footer">

  <div class="wrapper">

    <h2 class="footer-heading">Health informatics and information technology</h2>

    <div class="footer-col-wrapper">
      <div class="footer-col footer-col-1">
        <ul class="contact-list">
          <li>
            
              Health informatics and information technology
            
            </li>
            
            <li><a href="mailto:mark@wardle.org">mark@wardle.org</a></li>
            
        </ul>
      </div>

      <div class="footer-col footer-col-2">
        <ul class="social-media-list">
          
          <li>
            <a href="https://github.com/wardle"><span class="icon icon--github"><svg viewBox="0 0 16 16" width="16px" height="16px"><path fill="#828282" d="M7.999,0.431c-4.285,0-7.76,3.474-7.76,7.761 c0,3.428,2.223,6.337,5.307,7.363c0.388,0.071,0.53-0.168,0.53-0.374c0-0.184-0.007-0.672-0.01-1.32 c-2.159,0.469-2.614-1.04-2.614-1.04c-0.353-0.896-0.862-1.135-0.862-1.135c-0.705-0.481,0.053-0.472,0.053-0.472 c0.779,0.055,1.189,0.8,1.189,0.8c0.692,1.186,1.816,0.843,2.258,0.645c0.071-0.502,0.271-0.843,0.493-1.037 C4.86,11.425,3.049,10.76,3.049,7.786c0-0.847,0.302-1.54,0.799-2.082C3.768,5.507,3.501,4.718,3.924,3.65 c0,0,0.652-0.209,2.134,0.796C6.677,4.273,7.34,4.187,8,4.184c0.659,0.003,1.323,0.089,1.943,0.261 c1.482-1.004,2.132-0.796,2.132-0.796c0.423,1.068,0.157,1.857,0.077,2.054c0.497,0.542,0.798,1.235,0.798,2.082 c0,2.981-1.814,3.637-3.543,3.829c0.279,0.24,0.527,0.713,0.527,1.437c0,1.037-0.01,1.874-0.01,2.129 c0,0.208,0.14,0.449,0.534,0.373c3.081-1.028,5.302-3.935,5.302-7.362C15.76,3.906,12.285,0.431,7.999,0.431z"/></svg>
</span><span class="username">wardle</span></a>

          </li>
          

          
          <li>
            <a href="https://twitter.com/mwardle"><span class="icon icon--twitter"><svg viewBox="0 0 16 16" width="16px" height="16px"><path fill="#828282" d="M15.969,3.058c-0.586,0.26-1.217,0.436-1.878,0.515c0.675-0.405,1.194-1.045,1.438-1.809c-0.632,0.375-1.332,0.647-2.076,0.793c-0.596-0.636-1.446-1.033-2.387-1.033c-1.806,0-3.27,1.464-3.27,3.27 c0,0.256,0.029,0.506,0.085,0.745C5.163,5.404,2.753,4.102,1.14,2.124C0.859,2.607,0.698,3.168,0.698,3.767 c0,1.134,0.577,2.135,1.455,2.722C1.616,6.472,1.112,6.325,0.671,6.08c0,0.014,0,0.027,0,0.041c0,1.584,1.127,2.906,2.623,3.206 C3.02,9.402,2.731,9.442,2.433,9.442c-0.211,0-0.416-0.021-0.615-0.059c0.416,1.299,1.624,2.245,3.055,2.271 c-1.119,0.877-2.529,1.4-4.061,1.4c-0.264,0-0.524-0.015-0.78-0.046c1.447,0.928,3.166,1.469,5.013,1.469 c6.015,0,9.304-4.983,9.304-9.304c0-0.142-0.003-0.283-0.009-0.423C14.976,4.29,15.531,3.714,15.969,3.058z"/></svg>
</span><span class="username">mwardle</span></a>

          </li>
          
        </ul>
      </div>

      <div class="footer-col footer-col-3">
        <p>by Dr Mark Wardle, Consultant Neurologist, clinical informatics and software developer. Founder, Eldrix Ltd.
</p>
      </div>
    </div>

  </div>

</footer>


  </body>

</html>
